News Search

Editor's Note: Mark Bittman, author of this Opinion piece, is a lecturer in the Department of Health Policy and Management at the Columbia University Mailman School of Public Health.

Michel Sadelain, a global pioneer in CAR T-cell immunotherapy, will head the new Columbia Initiative in Cell Engineering and Therapy.

“These delusions take over their mind and their body,” said Dr. Margaret Spinelli, a clinical professor of psychiatry at Columbia University.